Search
Nicholas Colangelo, MD, PhD

A New Era of Radiotherapy

Nicholas Colangelo, MD, PhD

NYU Langone Health’s Perlmutter Cancer Center

Potentiating FLASH Radiotherapy Using SOD Mimetics in
Pancreatic Cancer

We are exploring a novel method to treat pancreatic cancer, which has one of the lowest rates of survival. Because the pancreas is located near many important organs, current treatments are often difficult or impossible. Radiation treatments for pancreatic cancer are limited by the sensitivity of the nearby bowel. FLASH radiation therapy (RT) is a new technology that delivers radiation much faster than current methods and has been shown to reduce radiation-induced damage in healthy tissues while still being effective against cancer. Using a pancreatic cancer model, we are testing whether FLASH RT and a class of drugs called superoxide dismutase (SOD) mimetics can shrink tumors and improve survival, while sparing the sensitive bowel. Our research aims to better understand how FLASH RT works and if SOD mimetics can amplify its effect. By combining these two emerging therapies, we hope to improve care and outcomes for people with pancreatic cancer.

Program:

A New Era of Radiotherapy
  • Year Awarded: 2023
  • Subject Area:
    Pancreatic Cancer;
    Imaging, Innovative Technologies and Expanded Indications; Tumor Microenvironment and Combination Therapies

251 18th Street South, 8th Floor
Arlington, VA 22202